Previous Article | Next Article 
Journal of Clinical Microbiology, August 2002, p. 2930-2935, Vol. 40, No. 8
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.8.2930-2935.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Clinical and Laboratory Features of Mycobacterium mageritense
Richard J. Wallace Jr.,1* Barbara A. Brown-Elliott,1 Leslie Hall,2 Glenn Roberts,2 Rebecca W. Wilson,1,3 Linda B. Mann,1 Christopher J. Crist,1 Sher H. Chiu,4 Robbie Dunlap,4 Maria J. Garcia,5 J. Todd Bagwell,6 and Kenneth C. Jost Jr.4
Departments of Microbiology,1
Pathology, University of Texas Health Center, Tyler,3
Mycobacteriology Mycology Branch, Texas Department of Health,4
Austin Infectious Disease Consultants, Austin, Texas,6
Mayo Clinic, Rochester, Minnesota,2
Departmento de Medicina Preventiva, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain5
Received 28 November 2001/
Returned for modification 22 January 2002/
Accepted 8 May 2002
Six clinical isolates of the nonpigmented, rapidly growing species Mycobacterium mageritense were recovered from sputum, bronchial wash, blood, sinus drainage, and two surgical wound infections from separate patients in Texas, New York, Louisiana, and Florida. The isolates matched the ATCC type strain by PCR restriction enzyme analysis of the 65-kDa hsp gene sequence of Telenti, high-performance liquid chromatography, biochemical reactions, and partial 16S rRNA gene sequencing. These are the first isolates of this species to be described in the United States and the first isolates to be associated with clinical disease. Susceptibility testing of all known isolates of the species revealed all isolates to be susceptible or intermediate to amikacin, cefoxitin, imipenem, and the fluoroquinolones and sulfonamides but resistant to clarithromycin. Because of their phenotypic and clinical similarity to isolates of the Mycobacterium fortuitum third biovariant complex (sorbitol positive), isolates of M. mageritense are likely to go undetected unless selected carbohydrate utilization or molecular identification methods are used.
* Corresponding author. Mailing address: The University of Texas Health Center, Department of Microbiology, 11937 US Hwy 271, Tyler, TX 75708. Phone: (903) 877-7680. Fax: (903) 877-7652. E-mail:
Richard.Wallace{at}uthct.edu.
Journal of Clinical Microbiology, August 2002, p. 2930-2935, Vol. 40, No. 8
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.8.2930-2935.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Nash, K. A., Brown-Elliott, B. A., Wallace, R. J. Jr.
(2009). A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae. Antimicrob. Agents Chemother.
53: 1367-1376
[Abstract]
[Full Text]
-
Morick, D., Kik, M., de Beer, J., van der Zanden, A. G. M., Houwers, D. J.
(2008). Isolation of Mycobacterium mageritense from the Lung of a Harbor Porpoise (Phocoena phocoena) with Severe Granulomatous Lesions. J Wildl Dis
44: 999-1001
[Abstract]
[Full Text]
-
Lamy, B., Marchandin, H., Hamitouche, K., Laurent, F.
(2008). Mycobacterium setense sp. nov., a Mycobacterium fortuitum-group organism isolated from a patient with soft tissue infection and osteitis. Int. J. Syst. Evol. Microbiol.
58: 486-490
[Abstract]
[Full Text]
-
Parrish, N., Osterhout, G., Dionne, K., Sweeney, A., Kwiatkowski, N., Carroll, K., Jost, K. C. Jr., Dick, J.
(2007). Rapid, Standardized Method for Determination of Mycobacterium tuberculosis Drug Susceptibility by Use of Mycolic Acid Analysis. J. Clin. Microbiol.
45: 3915-3920
[Abstract]
[Full Text]
-
Ali, S., Khan, F. A., Fisher, M.
(2007). Catheter-Related Bloodstream Infection Caused by Mycobacterium mageritense. J. Clin. Microbiol.
45: 273-273
[Full Text]
-
Cloud, J. L., Meyer, J. J., Pounder, J. I., Jost, K. C. Jr, Sweeney, A., Carroll, K. C., Woods, G. L.
(2006). Mycobacterium arupense sp. nov., a non-chromogenic bacterium isolated from clinical specimens. Int. J. Syst. Evol. Microbiol.
56: 1413-1418
[Abstract]
[Full Text]
-
Wallace, R. J. Jr., Brown-Elliott, B. A., Brown, J., Steigerwalt, A. G., Hall, L., Woods, G., Cloud, J., Mann, L., Wilson, R., Crist, C., Jost, K. C. Jr., Byrer, D. E., Tang, J., Cooper, J., Stamenova, E., Campbell, B., Wolfe, J., Turenne, C.
(2005). Polyphasic Characterization Reveals that the Human Pathogen Mycobacterium peregrinum Type II Belongs to the Bovine Pathogen Species Mycobacterium senegalense. J. Clin. Microbiol.
43: 5925-5935
[Abstract]
[Full Text]
-
Nash, K. A., Zhang, Y., Brown-Elliott, B. A., Wallace, R. J. Jr
(2005). Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother
55: 170-177
[Abstract]
[Full Text]
-
Wallace, R. J. Jr., Brown-Elliott, B. A., Wilson, R. W., Mann, L., Hall, L., Zhang, Y., Jost, K. C. Jr., Brown, J. M., Kabani, A., Schinsky, M. F., Steigerwalt, A. G., Crist, C. J., Roberts, G. D., Blacklock, Z., Tsukamura, M., Silcox, V., Turenne, C.
(2004). Clinical and Laboratory Features of Mycobacterium porcinum. J. Clin. Microbiol.
42: 5689-5697
[Abstract]
[Full Text]
-
Adekambi, T., Drancourt, M.
(2004). Dissection of phylogenetic relationships among 19 rapidly growing Mycobacterium species by 16S rRNA, hsp65, sodA, recA and rpoB gene sequencing. Int. J. Syst. Evol. Microbiol.
54: 2095-2105
[Abstract]
[Full Text]
-
Selvarangan, R., Wu, W.-K., Nguyen, T. T., Carlson, L. D. C., Wallis, C. K., Stiglich, S. K., Chen, Y.-C., Jost, K. C. Jr., Prentice, J. L., Wallace, R. J. Jr., Barrett, S. L. R., Cookson, B. T., Coyle, M. B.
(2004). Characterization of a Novel Group of Mycobacteria and Proposal of Mycobacterium sherrisii sp. nov.. J. Clin. Microbiol.
42: 52-59
[Abstract]
[Full Text]
-
Adekambi, T., Colson, P., Drancourt, M.
(2003). rpoB-Based Identification of Nonpigmented and Late-Pigmenting Rapidly Growing Mycobacteria. J. Clin. Microbiol.
41: 5699-5708
[Abstract]
[Full Text]
-
Nash, K. A.
(2003). Intrinsic Macrolide Resistance in Mycobacterium smegmatis Is Conferred by a Novel erm Gene, erm(38). Antimicrob. Agents Chemother.
47: 3053-3060
[Abstract]
[Full Text]
-
Yang, S.-C., Hsueh, P.-R., Lai, H.-C., Teng, L.-J., Huang, L.-M., Chen, J.-M., Wang, S.-K., Shie, D.-C., Ho, S.-W., Luh, K.-T.
(2003). High Prevalence of Antimicrobial Resistance in Rapidly Growing Mycobacteria in Taiwan. Antimicrob. Agents Chemother.
47: 1958-1962
[Abstract]
[Full Text]
-
Tortoli, E.
(2003). Impact of Genotypic Studies on Mycobacterial Taxonomy: the New Mycobacteria of the 1990s. Clin. Microbiol. Rev.
16: 319-354
[Abstract]
[Full Text]
-
Brown-Elliott, B. A., Wallace, R. J. Jr.
(2002). Clinical and Taxonomic Status of Pathogenic Nonpigmented or Late-Pigmenting Rapidly Growing Mycobacteria. Clin. Microbiol. Rev.
15: 716-746
[Abstract]
[Full Text]